Full article reprinted from PharmAsia News December 23, 2008
In a review of the major legal and regulatory measures that changed China's healthcare landscape in 2008, Chinese and European lawyers stated the merger of the State FDA into the Ministry of Health is likely to have the most significant impact into the future. Find out why...
Continue reading "2008 In Review: China’s Major Legal & Regulatory Changes For Healthcare Sector" »
Article preview from Start-Up December 23, 2008
In 2007, what did Series A venture investments reveal about the state of the health care industry? It was very healthy, thank you. There were quite a few deals to choose from, and numbers demonstrated continued growth in diagnostics fundraising, a resurgence in vaccines, and evidence of pharma's interest in proof-of-concept projects and large-molecule platforms. Read more...
Continue reading "The A-List: 2007's Trend Shaping Series A Financings" »
Article preview from "IN VIVO" December 23, 2008
Pharma has weathered its share of economic downturns, but the data shows that the industry could be in for a tough winter. Prolonged cutbacks by consumers failing to refill prescriptions in tough economic times could become yet another obstacle for drug manufacturers already facing plenty of challenges in the coming year in the form of patent expirations, lackluster pipelines and stricter regulatory oversight. Find out more...
Continue reading "Economic Forecast for Pharma: Winter Weather Advisory Ahead" »
Full Article reprinted from "The Pink Sheet" December 23, 2008
Merck's fledgling bioventures business may have dominated headlines following the company's recent analyst day, but the firm's other initiatives are likely to contribute more to near-term growth as Merck tries to address the revenue gap that will be left by key patent expirations in the next few years. Read more...
Continue reading "Merck Outlines Plans For 2009 NDA Filings; Migraine Drug Is Best Bet " »
Full preview from "The Pink Sheet" DAILY December 23, 2008
House Ways and Means Health Subcommittee Chairman Pete Stark, D-Calif., is predicting that any congressional votes on comprehensive health care reform legislation will take place toward the end of 2009 or, at the latest, early the following year. Find out why...
Continue reading "Rep. Stark Sees Health Reform Votes In Late 2009/Early 2010, “Deferred Maintenance” Items Sooner" »
Article reprinted from "The RPM Report" December 23, 2008
Find out why Health care reform advocates think the stars are aligned for a major push toward universal coverage under President-elect Barack Obama. They aren’t about to let the free-falling economy get in the way.
Continue reading "Prioritizing Health Care: Reform Gains Early Momentum " »
Article preview from "The Pink Sheet" December 23, 2008
When discussing a drug's benefits and risks, there is more to the equation than just death, Judith Kramer, Duke University, pointed out during a meeting of three FDA advisory committees to discuss asthma indications for long-acting beta agonists. Read more now...
Continue reading "Death Vs. Symptomatic Relief – Weighing Risks And Benefits For Asthma Drugs " »